文献速递腹部介入技术与安全MR

基于肝胆期MRI的个性化3D打印透明肝脏模型:在局灶性肝脏病灶逐病灶影像-病理匹配中的初步应用

Personalized 3D-Printed Transparent Liver Model Using the Hepatobiliary Phase MRI: Usefulness in the Lesion-by-Lesion Imaging-Pathologic Matching of Focal Liver Lesions-Preliminary Results.
PubMed 文献 · Invest Radiol · 2019-01-01

这项前瞻性初步研究纳入20例有多发局灶性肝脏病灶的患者,利用钆塞酸增强MRI肝胆期图像制作个性化3D打印透明肝脏模型,用于大体标本逐病灶检出。模型辅助下大体检查病灶检出率为99.0%(97/98),显著高于常规检查的82.7%(81/98)(P < 0.001),≤10 mm病灶中23.9%(16/67)经模型额外检出。

要点

  • 3D打印透明肝脏模型辅助大体检查病灶检出率99.0%(97/98),常规检查为82.7%(81/98),P < 0.001。
  • ≤10 mm病灶中23.9%(16/67)经模型额外检出,>10 mm病灶无额外检出。
  • 额外检出的16个病灶含存活转移灶、转移灶病理完全缓解、肝细胞癌、局灶性结节性增生样结节及血管瘤。

核心结论

  • 个性化3D打印透明肝脏模型可能改善小局灶性肝脏病灶的逐病灶影像-病理匹配,从而有助于准确的病理肿瘤分期,并为影像检出的病灶提供可靠参照。

研究设计与样本

  • 前瞻性初步研究,经机构审查委员会批准并获书面知情同意;纳入20例(男:女=13:7,平均年龄56岁)术前钆塞酸增强MRI显示多发局灶性肝脏病灶、且至少一个疑为恶性或一个10 mm及以下性质不定病灶的患者;对肝胆期MRI进行数字分割后制作透明3D打印肝脏模型,解剖结构与病灶着色;比较大体检查时无模型辅助(常规方案)与有模型辅助的逐病灶检出率。

关键影像表现/征象

  • MRI检出98个局灶性肝脏病灶,平均大小11.5 ± 12.5 mm。
  • 模型辅助大体检查逐病灶检出率99.0%(97/98),常规检查为82.7%(81/98),P < 0.001。
  • 按肿瘤大小亚组分析,≤10 mm病灶中23.9%(16/67)经肝脏模型额外检出,>10 mm病灶无额外检出。
  • 额外检出的16个病灶分布于12例患者,组织学诊断包括存活转移灶、转移灶病理完全缓解、肝细胞癌、局灶性结节性增生样结节及血管瘤。

诊断标准与关键数值

  • 以钆塞酸增强MRI肝胆期图像数字分割制作的3D打印透明肝脏模型作为大体检查定位辅助,与常规大体检查比较逐病灶检出率。
  • MRI检出病灶98个(11.5 ± 12.5 mm),模型辅助检出97/98(99.0%),常规检出81/98(82.7%),P < 0.001。
  • ≤10 mm病灶67个中模型额外检出16个(23.9%),>10 mm病灶无额外检出。

临床应用与阅片要点

  • 作者认为个性化3D打印透明肝脏模型可能改善小局灶性肝脏病灶的逐病灶影像-病理匹配。
  • 作者认为该模型可能有助于准确的病理肿瘤分期,并为影像检出的病灶提供可靠参照。

局限性

  • 原文标题标注为初步结果(Preliminary Results)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: The aim of this study was to investigate the usefulness of a personalized, 3-dimensional (3D)-printed, transparent liver model with focal liver lesions (FLLs) for lesion-by-lesion imaging-pathologic matching.

MATERIALS AND METHODS: This preliminary, prospective study was approved by our institutional review board, and written informed consent was obtained. Twenty patients (male-to-female ratio, 13:7; mean age, 56 years) with multiple FLLs, including at least one presumed malignant, or an indeterminate lesion 10 mm or less on the preoperative gadoxetic acid-enhanced magnetic resonance imaging (MRI), were included. After digital segmentation of hepatobiliary phase MRI, a transparent, 3D-printed liver model with colored anatomical structures and FLLs was produced. During the gross examination of the liver specimen, the per-lesion detection rates were compared between those without (routine protocol) and those with the aid of the 3D-printed liver model.

RESULTS: Among 98 MRI-detected FLLs (11.5 ± 12.5 mm), the per-lesion detection rate on gross examination using the 3D-printed liver model was 99.0% (97/98), which was significantly higher than that obtained on routine examination (82.7% [81/98]; P < 0.001). In the subgroup analysis, according to the tumor size, 23.9% (16/67) of FLLs 10 mm or less were additionally detected using the liver model, whereas none were additionally detected in greater than 10 mm. The additionally detected 16 FLLs in 12 patients included histologic diagnoses of viable metastases, pathologic complete response of metastases, hepatocellular carcinomas, focal nodular hyperplasia-like nodules, and hemangiomas.

CONCLUSIONS: A personalized, 3D-printed liver model with FLLs may improve the lesion-by-lesion imaging-pathologic matching for small FLLs, thus leading to accurate pathologic tumor staging and obtaining a reliable reference for imaging-detected FLLs.

来源:Invest Radiol,查看原文。版权归原作者所有。

引用

  1. Joo I, Kim JH, Park SJ, et al. Personalized 3D-Printed Transparent Liver Model Using the Hepatobiliary Phase MRI: Usefulness in the Lesion-by-Lesion Imaging-Pathologic Matching of Focal Liver Lesions-Preliminary Results. Invest Radiol. 2019. PMID: 30379728. doi:10.1097/RLI.0000000000000521

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。